DMAC
DiaMedica Therapeutics Inc
7.60$
-2.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
DiaMedica Therapeutics Inc (DMAC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -8.1 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.8 | -3.8 | -6.7 | -4.5 | -4.5 | -6.4 | -7.1 | -7.6 | -6.6 | -7.8 | -9.1 | -8.1 | -32 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.4 | 0.5 | 0.5 | 0.4 | 0.6 | 0.6 | 0.9 | 0.8 | 1.0 | 1.2 | 0.8 | 1.1 | 4.1 | |
| -0.4 | 1.2 | -1.7 | 0.4 | 1.6 | 1.2 | -0.1 | -0.5 | 1.3 | 0.0 | 0.3 | 1.0 | 2.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.2 | 6.1 | 4.2 | 4.7 | -5.6 | 5.2 | 6.6 | 9.0 | -26 | 8.0 | -2.1 | 8.2 | -12 | |
| 0.0 | -410 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 12 | 0.1 | 0.1 | 0.1 | 0.2 | 32 | 12 | 0.4 | 0.1 | 45 | |
| -3.6 | 2.3 | -2.4 | 12 | -9.9 | -1.1 | -0.4 | 1.5 | -0.8 | 12 | -11 | 0.3 | 1.0 | |
| -4.8 | -3.8 | -6.7 | -4.5 | -4.5 | -6.4 | -7.2 | -7.6 | -6.6 | -7.8 | -9.1 | -8.1 | -32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.